Welcome to
On Feet Nation
Steven Online
Linda Online
Donald Jimenez Online
Emcure Pharmaceuticals Ltd is seeing new growth opportunities in biologics and vaccines which it intends to introduce in various emerging markets. Being the first Indian company to have developed an indigenous mRNA platform, it is in the process of developing an mRNA COVID-19 vaccine via its subsidiary Gennova Biopharmaceuticals Ltd., for which it has received funding from the Government of India. Three other vaccines on its mRNA platform are in development stages, targeted at Zoster, Zika and Rabies, said Satish Mehta, MD and CEO.
Read more at https://www.thehindu.com/business/booster-shots-pediatric-jabs-to-k...
© 2024 Created by PH the vintage. Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation